2+ hour, 7+ min ago   (69+ words) Kalkine Media OncoSil Medical (ASX:OSL) OSL (ASX:OSL) announced a change in substantial holder interests from Regal Partners Funds Management Pty Limited and its associates, revealing their voting power rose from 9.25% to 13.82%. This is based on the total shares…...

4+ hour, 31+ min ago   (942+ words) Last May, US President Donald Trump pushed to align drug pricing with the lowest levels among other developed nations — so-called most-favoured-nation (MFN) pricing. However, the pricing policy might have negative consequences. European patients might have to wait longer for some…...

6+ hour, 48+ min ago   (69+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Jiangsu Hengrui Pharmaceuticals Co.,Ltd Hengrui Pharmaceuticals' Lung Cancer…...

3+ hour, 20+ min ago   (318+ words) BioSpace Aptar Pharma Expands Preservative Free Technology Production in Latin America Transfer of Aptar Pharma’s Advanced Preservative Free pump technology to Berazategui, Argentina, strengthens local manufacturing capabilities and supports the company’s local-for-local approach in the region. Located south of Buenos…...

8+ hour, 15+ min ago   (339+ words) Joint Projects With SurgeneX, PinotBio and PulseInMyEars Programs Span mRNA Eye Drops, ADC and Peptide Cancer Drug Huons is moving to develop drug candidates across three different modalities — an mRNA eye drop, an antibody-drug conjugate (ADC) and a peptide cancer…...

8+ hour, 22+ min ago   (980+ words) When AI pushes drug design to the "minute-level", laboratories capable of validating such outputs are equally scarce. Swiss startup Adaptyv Bio completed wet experimental validation of 1320 protein sequences for Anthropic's Claude. Its revenue has increased nearly 10 times in the past…...

16+ hour, 29+ min ago   (165+ words) • A deal for Sofie, which specializes in radioactive chemicals used in cancer scans, could be announced as soon as next week, the report said. • Reuters could not immediately verify the report. GE HealthCare declined to comment while Sofie Biosciences could…...

9+ hour, 40+ min ago   (324+ words) GE HealthCare’s contrast media manufacturing site in Cork, Ireland. GE HealthCare is looking to buy Sofie Biosciences, a private-equity backed business that develops radiopharmaceuticals used for cancer diagnostics and treatment. The deal, which could be announced next week, is said…...

10+ hour, 33+ min ago   (58+ words) The Times Lung cancer results boost GSK’s plan to rebuild oncology business The British pharma company presents more positive data for Jideytro, which could become a first-line treatment for certain lung tumours £1 for 3 months Enjoy unlimited access to all articles....

7+ hour ago   (632+ words) As allegations mount that Kim Seung-won, nominee for South Korea's Justice Minister, lobbied for Genencell's COVID-19 treatment clinical trial, evidence has emerged that capital market players who profited handsomely from Genencell-related stock investments in 2020 repeated the same pattern in 2021. Yoo…...